Cargando…

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis

Background: Recently, many studies have explored the relationship between the expression of programmed death ligand 1 (PD-L1) and prognosis in gastric cancer, but there is still controversy. Additionally, few studies have specifically investigated the expression of PD-L1 in patients with peritoneal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiao-Jiang, Wei, Cheng-Zhi, Lin, Jun, Zhang, Ruo-Peng, Chen, Guo-Ming, Li, Yuan-Fang, Nie, Run-Cong, Chen, Yong-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377298/ https://www.ncbi.nlm.nih.gov/pubmed/37509642 http://dx.doi.org/10.3390/biomedicines11072003

Ejemplares similares

Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
por: Chen, Shi, et al.
Publicado: (2017)

Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis
por: Yuan, Shu-Qiang, et al.
Publicado: (2017)

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2021)

Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2017)

Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination
por: Nie, Runcong, et al.
Publicado: (2016)

Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer
por: Chen, Shi, et al.
Publicado: (2017)

Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer
por: Sun, YuQin, et al.
Publicado: (2023)

Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer
por: Zhao, Bai-Wei, et al.
Publicado: (2015)

The Prognostic and Therapeutic Value of PD-L1 in Glioma
por: Chen, Ruo Qiao, et al.
Publicado: (2019)

Bursectomy for advanced gastric cancer: an update meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2018)

Prognostic Value of the Nutritional Risk Screening 2002 Scale in Metastatic Gastric Cancer: A Large-Scale Cohort Study
por: Li, Yuan-Fang, et al.
Publicado: (2019)

Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
por: Liu, Yong-Xuan, et al.
Publicado: (2016)

Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2019)

Metastasis, Risk Factors and Prognostic Significance of Splenic Hilar Lymph Nodes in Gastric Adenocarcinoma
por: Chen, Xiao-Long, et al.
Publicado: (2014)

Recent Findings in the Posttranslational Modifications of PD-L1
por: Li, Shu-Man, et al.
Publicado: (2020)

Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
por: Ding, Youcheng, et al.
Publicado: (2013)

Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
por: Zheng, Ling-Nan, et al.
Publicado: (2019)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

The Diagnostic and Prognostic Value of Digital Rectal Examination in Gastric Cancer Patients with Peritoneal Metastasis
por: Guo, Jing, et al.
Publicado: (2019)

Issues on peritoneal metastasis of gastric cancer: an update
por: Wang, Zhen, et al.
Publicado: (2019)

Prognostic significance of PD‐L1 expression on cell‐surface vimentin‐positive circulating tumor cells in gastric cancer patients
por: Liu, Mengyuan, et al.
Publicado: (2020)

The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2020)

Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020)

Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis
por: Deng, Kai, et al.
Publicado: (2016)

CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis
por: Li, Jiazheng, et al.
Publicado: (2023)

Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
por: Zhang, You-Cheng, et al.
Publicado: (2023)

Levels and Significance of Tumor Markers and Cytokines in Serum and Peritoneal Lavage Fluid of Patients with Peritoneal Metastasis of Gastric Cancer
por: Yang, Jianqi, et al.
Publicado: (2022)

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
por: Zhu, Xinxin, et al.
Publicado: (2017)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

Prognostic significance and the role in TNM stage of extranodal metastasis within regional lymph nodes station in gastric carcinoma
por: Chen, Xiao-Long, et al.
Publicado: (2016)

Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Can visceral fat parameters based on computed tomography be used to predict occult peritoneal metastasis in gastric cancer?
por: Li, Li-Ming, et al.
Publicado: (2023)

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2020)

Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis
por: Wang, Qianqian, et al.
Publicado: (2017)

CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer
por: Yu, Qi-Ming, et al.
Publicado: (2012)

Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma
por: Nie, Run-Cong, et al.
Publicado: (2019)

Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis
por: Song, Hongjiang, et al.
Publicado: (2019)

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials
por: Zhao, Bai-Wei, et al.
Publicado: (2022)

Editorial: Peritoneal metastasis of gastric cancer
por: Wang, Shuyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_80eatta0hccso0v29abbb2rcm4